Ligand Pharmaceuticals
Price & Volume
Stats
See more52W Range | $93.58-$157.54 |
Market Cap | $3B |
Shares Short | 915,900 |
Financials
See moreRevenue (12 Mos) | $187.5M |
Revenue Growth (YoY) | 14.7% |
Gross Profit (12 Mos) | $107.7M |
Diluted EPS | -$4.04 |
News
See moreYahoo Finance • 5 days ago
Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering
Yahoo Finance • 5 days ago
Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030
Yahoo Finance • 9 days ago
Ligand Pharmaceuticals (NASDAQ:LGND) Surpasses Q2 2025 Earnings Estimates with Strong Royalty Growth
Yahoo Finance • 9 days ago
Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance
About
CEO | Mr. Todd C. Davis Ph.D. |
Address | 555 Heritage Drive, Jupiter, FL, United States, 33458 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 68 |
